PDF herunterladen
Facial Plast Surg 2014; 30(06): 623-627
DOI: 10.1055/s-0034-1396756
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Management of Complications of Injectable Silicone

Doris Hexsel
1   Brazilian Center for Studies in Dermatology, Porto Alegre, RS, Brazil
2   Pontificia Universidade Catolica do Rio Grande do Sul, Porto Alegre, RS, Brazil
,
Marina Resener de Morais
1   Brazilian Center for Studies in Dermatology, Porto Alegre, RS, Brazil
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
23. Dezember 2014 (online)

    Lizenzen und Reprints

Abstract

Soft tissue augmentation is a common procedure, and a wide variety of injectable fillers are used. Liquid injectable silicone (LIS) was the first highly popularized injectable filler. LIS is a permanent filler and can be used in the correction of facial furrows and wrinkles. Some complications are inherent to the procedure and can resolve spontaneously, such as redness, swelling, and immediate hypersensitivity reactions. Unintended reactions, such as granulomas, infections, vascular occlusion, can also follow the treatment with LIS and may appear several years after the injections. These can be difficult to manage, show little or no tendency to spontaneous resolutions, and rarely resolve completely. Injecting physicians must be aware of these potential complications caused by LIS because early medical care and treatment, including psychological support for these patients, can minimize the consequences for patients and physicians, and may also help obtaining better outcomes when treating complications.

Keywords

dermal fillers - injectable augmentation - silicone - complications
 

  • References

  • 1 Fischer J, Metzler G, Schaller M. Cosmetic permanent fillers for soft tissue augmentation: a new contraindication for interferon therapies. Arch Dermatol 2007; 143 (4) 507-510
    CrossrefPubMedGoogle Scholar
  • 2 Dayan SH, Ellis DA, Moran ML. Facial fillers: discussion and debate. Facial Plast Surg Clin North Am 2012; 20 (3) 245-264
    CrossrefPubMedGoogle Scholar
  • 3 Duffy DM. The silicone conundrum: a battle of anecdotes. Dermatol Surg 2002; 28 (7) 590-594
    CrossrefPubMedGoogle Scholar
  • 4 Orentreich DS, Orentreich N. Injectable fluid silicone. In: Roenigk RK, Roenigk Jr HH, , eds. Dermatologic Surgery: Principles and Practice. New York: Marcel Dekker; 1989: 1349-1395
    Google Scholar
  • 5 Narins RS. Minimizing adverse events associated with poly-L-lactic acid injection. Dermatol Surg 2008; 34 (Suppl. 01) S100-S104
    CrossrefPubMedGoogle Scholar
  • 6 Daines SM, Williams EF. Complications associated with injectable soft-tissue fillers: a 5-year retrospective review. JAMA Facial Plast Surg 2013; 15 (3) 226-231
    CrossrefPubMedGoogle Scholar
  • 7 Requena L, Requena C, Christensen L, Zimmermann US, Kutzner H, Cerroni L. Adverse reactions to injectable soft tissue fillers. J Am Acad Dermatol 2011; 64 (1) 1-34 , quiz 35–36
    Google Scholar
  • 8 Hexsel DM, Hexsel CL, Iyengar V. Liquid injectable silicone: history, mechanism of action, indications, technique, and complications. Semin Cutan Med Surg 2003; 22 (2) 107-114
    CrossrefPubMedGoogle Scholar
  • 9 Duffy DM. Tissue injectable liquid silicone: new perspectives. In: Klein AW, , ed. Augmentation in Clinical Practice: Procedures and Techniques. New York: Marcel Dekker; 1998: 237-267
    Google Scholar
  • 10 Cohen JL. Understanding, avoiding, and managing dermal filler complications. Dermatol Surg 2008; 34 (Suppl. 01) S92-S99
    CrossrefPubMedGoogle Scholar
  • 11 Selmanowitz VJ, Orentreich N. Medical-grade fluid silicone. A monographic review. J Dermatol Surg Oncol 1977; 3 (6) 597-611
    CrossrefPubMedGoogle Scholar
  • 12 Lowe NJ, Maxwell CA, Patnaik R. Adverse reactions to dermal fillers: review. Dermatol Surg 2005; 31 (11, Pt 2) 1616-1625
    PubMedGoogle Scholar
  • 13 Lemperle G, Romano JJ, Busso M. Soft tissue augmentation with artecoll: 10-year history, indications, techniques, and complications. Dermatol Surg 2003; 29 (6) 573-587 , discussion 587
    CrossrefPubMedGoogle Scholar
  • 14 White MI, Smart LM, Macgregor DM, Rayner CR, Smith FW. Recurrent facial oedema associated with a silicone-rubber implant. Br J Dermatol 1991; 125 (2) 183-185
    CrossrefPubMedGoogle Scholar
  • 15 Prather CL, Jones DH. Liquid injectable silicone for soft tissue augmentation. Dermatol Ther 2006; 19 (3) 159-168
    CrossrefPubMedGoogle Scholar
  • 16 Wilkie TF. Late development of granuloma after liquid silicone injections. Plast Reconstr Surg 1977; 60 (2) 179-188
    CrossrefPubMedGoogle Scholar
  • 17 Rudolph R, Abraham J, Vecchione T, Guber S, Woodward M. Myofibroblasts and free silicone around breast implants. Plast Reconstr Surg 1979; 63 (5) 719-720
    PubMedGoogle Scholar
  • 18 Lloret P, España A, Leache A , et al. Successful treatment of granulomatous reactions secondary to injection of esthetic implants. Dermatol Surg 2005; 31 (4) 486-490
    CrossrefPubMedGoogle Scholar
  • 19 Monheit GD, Rohrich RJ. The nature of long-term fillers and the risk of complications. Dermatol Surg 2009; 35 (Suppl. 02) 1598-1604
    CrossrefPubMedGoogle Scholar
  • 20 Christensen L. Normal and pathologic reactions to soft tissue gel fillers. Dermatol Surg 2007; 33 (Suppl. 02) S168-S175
    CrossrefPubMedGoogle Scholar
  • 21 Franz FP, Blocksma R, Brundage SR, Ringler SL. Massive injection of liquid silicone for hemifacial atrophy. Ann Plast Surg 1988; 20 (2) 140-145
    CrossrefPubMedGoogle Scholar
  • 22 Duffy DM. Silicone: a critical review. Adv Dermatol 1990; 5: 93-107; discussion 108–109
    PubMedGoogle Scholar
  • 23 Reisberger EM, Landthaler M, Wiest L, Schröder J, Stolz W. Foreign body granulomas caused by polymethylmethacrylate microspheres: successful treatment with allopurinol. Arch Dermatol 2003; 139 (1) 17-20
    CrossrefPubMedGoogle Scholar
  • 24 Baumann LS, Halem ML. Lip silicone granulomatous foreign body reaction treated with aldara (imiquimod 5%). Dermatol Surg 2003; 29 (4) 429-432
    PubMedGoogle Scholar
  • 25 Mertz PM. Cutaneous biofilms: friend or foe?. Wounds 2003; 15 (5) 129-132
    PubMedGoogle Scholar
  • 26 Sclafani AP, Fagien S. Treatment of injectable soft tissue filler complications. Dermatol Surg 2009; 35 (Suppl. 02) 1672-1680
    CrossrefPubMedGoogle Scholar
  • 27 Ellenbogen R, Rubin L. Injectable fluid silicone therapy. Human morbidity and mortality. JAMA 1975; 234 (3) 308-309
    CrossrefPubMedGoogle Scholar